Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Abstract Background The 4 dengue serotypes (DENV) are mosquito-borne pathogens that are associated with severe hemorrhagic disease. DENV particles have a lipid bilayer envelope that anchors two membrane glycoproteins prM and E. Two E-protein monomers form head-to-tail homodimers and three E-dimers a...
| Published in: | Virology Journal |
|---|---|
| Main Authors: | Stefan W. Metz, Ashlie Thomas, Laura White, Mark Stoops, Markus Corten, Holger Hannemann, Aravinda M. de Silva |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-04-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12985-018-0970-2 |
Similar Items
Exploring dengue genome to design effective multi epitope-based peptide vaccine by immunoinformatics approach against all serotypes of dengue virus
by: Md. Sadman Sakib, et al.
Published: (2024-01-01)
by: Md. Sadman Sakib, et al.
Published: (2024-01-01)
Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains
by: Devina J. Thiono, et al.
Published: (2025-05-01)
by: Devina J. Thiono, et al.
Published: (2025-05-01)
Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1
by: Nikole L. Warner, et al.
Published: (2021-07-01)
by: Nikole L. Warner, et al.
Published: (2021-07-01)
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
by: Deanna R. Zhu, et al.
Published: (2023-10-01)
by: Deanna R. Zhu, et al.
Published: (2023-10-01)
Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates
by: Yadya M. Chawla, et al.
Published: (2024-05-01)
by: Yadya M. Chawla, et al.
Published: (2024-05-01)
Epitope of dengue virus E protein detect human antibodies associated with mild disease: a potential peptide for vaccine development
by: Gilma Sánchez-Burgos, et al.
Published: (2020-01-01)
by: Gilma Sánchez-Burgos, et al.
Published: (2020-01-01)
[IN1438] Dengue and Dengue Virus in Florida
by: Yasmin V. Ortiz, et al.
Published: (2025-02-01)
by: Yasmin V. Ortiz, et al.
Published: (2025-02-01)
Delineating blueprint of an epitope-based peptide vaccine against the multiple serovars of dengue virus: A hierarchical reverse vaccinology approach
by: Rahatul Islam, BSc, et al.
Published: (2020-01-01)
by: Rahatul Islam, BSc, et al.
Published: (2020-01-01)
Molecular epidemiology of dengue viruses in Brazil Epidemiologia molecular dos vírus dengue no Brasil
by: Rita Maria Ribeiro Nogueira, et al.
Published: (2000-01-01)
by: Rita Maria Ribeiro Nogueira, et al.
Published: (2000-01-01)
Discovery of Potent Degraders of the Dengue Virus Envelope Protein
by: Zhengnian Li, et al.
Published: (2024-10-01)
by: Zhengnian Li, et al.
Published: (2024-10-01)
Enveloped virus-like particles as a platform for vaccine development
by: Francisco Diaz-Mitoma
Published: (2021-01-01)
by: Francisco Diaz-Mitoma
Published: (2021-01-01)
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach
by: Gunjan Uttam, et al.
Published: (2023-01-01)
by: Gunjan Uttam, et al.
Published: (2023-01-01)
Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice
by: Qian Li, et al.
Published: (2024-04-01)
by: Qian Li, et al.
Published: (2024-04-01)
DENV-Mimetic Polymersome Nanoparticles Bearing Multi-Epitope Lipopeptides Antigen as the Next-Generation Dengue Vaccine
by: Nur Adilah Abdul Rahman, et al.
Published: (2022-01-01)
by: Nur Adilah Abdul Rahman, et al.
Published: (2022-01-01)
Hypocalcemia is associated with disease severity in patients with dengue
by: Godwin R Constantine, et al.
Published: (2014-09-01)
by: Godwin R Constantine, et al.
Published: (2014-09-01)
Ternary Nanostructure Coupling Flip-Flap Origami-Based Aptasensor for the Detection of Dengue Virus Antigens
by: Mohd. Rahil Hasan, et al.
Published: (2024-01-01)
by: Mohd. Rahil Hasan, et al.
Published: (2024-01-01)
Dengue virus serotypes and related factors in children with dengue hemorrhagic fever in Southern Vietnam
by: Khai Quang Tran, et al.
Published: (2024-04-01)
by: Khai Quang Tran, et al.
Published: (2024-04-01)
Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
by: Jisang Park, et al.
Published: (2020-02-01)
by: Jisang Park, et al.
Published: (2020-02-01)
Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity
by: Guntur Fibriansah, et al.
Published: (2021-07-01)
by: Guntur Fibriansah, et al.
Published: (2021-07-01)
The Human Antibody Response to Dengue Virus Infection
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)
An In Silico Design of a Vaccine against All Serotypes of the Dengue Virus Based on Virtual Screening of B-Cell and T-Cell Epitopes
by: Hikmat Ullah, et al.
Published: (2024-08-01)
by: Hikmat Ullah, et al.
Published: (2024-08-01)
Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
by: Mohd Ishtiaq Anasir, et al.
Published: (2020-03-01)
by: Mohd Ishtiaq Anasir, et al.
Published: (2020-03-01)
In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines
by: Lyn Marielle I. Abesamis, et al.
Published: (2022-08-01)
by: Lyn Marielle I. Abesamis, et al.
Published: (2022-08-01)
Clinical Predictors of Severe Dengue
by: Qurrat-Ul-Ain Usmani, et al.
Published: (2025-04-01)
by: Qurrat-Ul-Ain Usmani, et al.
Published: (2025-04-01)
The reemergence of dengue virus in Sudan
by: Mujahed I. Mustafa, et al.
Published: (2023-09-01)
by: Mujahed I. Mustafa, et al.
Published: (2023-09-01)
Identification of B-Cell Epitopes with Potential to Serologicaly Discrimnate Dengue from Zika Infections
by: Alice F. Versiani, et al.
Published: (2019-11-01)
by: Alice F. Versiani, et al.
Published: (2019-11-01)
A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study
by: Alena Reguzova, et al.
Published: (2021-12-01)
by: Alena Reguzova, et al.
Published: (2021-12-01)
Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
by: Subenya Injampa, et al.
Published: (2017-11-01)
by: Subenya Injampa, et al.
Published: (2017-11-01)
Mature dengue virus particles inactivated by a non-ionic detergent retain quaternary neutralizing epitopes and induce potent neutralizing antibodies
by: Wen-Yang Tsai, et al.
Published: (2025-09-01)
by: Wen-Yang Tsai, et al.
Published: (2025-09-01)
An outbreak of dengue virus at Rio de Janeiro - 1986
by: Hermann G. Schatzmayr, et al.
Published: (1986-06-01)
by: Hermann G. Schatzmayr, et al.
Published: (1986-06-01)
Dengue Virus 3 Genotype 1 Associated with Dengue Fever and Dengue Hemorrhagic Fever, Brazil
by: Leandra Barcelos Figueiredo, et al.
Published: (2008-02-01)
by: Leandra Barcelos Figueiredo, et al.
Published: (2008-02-01)
Dengue virus infections and anti-dengue virus activities of Andrographis paniculata
by: Mohamed Ali-Seyed, et al.
Published: (2020-01-01)
by: Mohamed Ali-Seyed, et al.
Published: (2020-01-01)
Epidemiological features of dengue fever and envelope gene of dengue virus among imported and indigenous cases in Guangzhou city: a comparison analysis on registry data of 2019
by: Li-yun JIANG, et al.
Published: (2022-11-01)
by: Li-yun JIANG, et al.
Published: (2022-11-01)
A Study of Serum Ferritin Level in Patients of Dengue Fever and Its Correlation with the Se-verity of Dengue Fever in Tertiary Care Hospital of South Gujarat
by: Maulikkumar K Prajapati, et al.
Published: (2022-12-01)
by: Maulikkumar K Prajapati, et al.
Published: (2022-12-01)
Seroprevalence of Dengue virus among pregnant mothers and their-newborn infants in the southwest of Saudi Arabia
by: Ali S. Alqahtani
Published: (2020-10-01)
by: Ali S. Alqahtani
Published: (2020-10-01)
Cloning and Expression of Domain III of Dengue Virus Type 2 Envelope Protein in Escherichia Coli
by: Hossein Fahimi, et al.
Published: (2013-07-01)
by: Hossein Fahimi, et al.
Published: (2013-07-01)
Hepatitis reactive to Dengue virus
by: Sarah María Regueira Betancourt, et al.
Published: (2016-02-01)
by: Sarah María Regueira Betancourt, et al.
Published: (2016-02-01)
Dominance of dengue virus serotype-2 in Pakistan (2023–2024): Molecular characterization of the envelope gene and exploration of antiviral targets
by: Haidar Ali, et al.
Published: (2024-12-01)
by: Haidar Ali, et al.
Published: (2024-12-01)
Dengue outbreak 2019: clinical and laboratory profiles of dengue virus infection in Dhaka city
by: Rudbar Mahmood, et al.
Published: (2021-06-01)
by: Rudbar Mahmood, et al.
Published: (2021-06-01)
Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach
by: Saurav Mandal, et al.
Published: (2025-02-01)
by: Saurav Mandal, et al.
Published: (2025-02-01)
Similar Items
-
Exploring dengue genome to design effective multi epitope-based peptide vaccine by immunoinformatics approach against all serotypes of dengue virus
by: Md. Sadman Sakib, et al.
Published: (2024-01-01) -
Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains
by: Devina J. Thiono, et al.
Published: (2025-05-01) -
Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1
by: Nikole L. Warner, et al.
Published: (2021-07-01) -
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
by: Deanna R. Zhu, et al.
Published: (2023-10-01) -
Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates
by: Yadya M. Chawla, et al.
Published: (2024-05-01)
